Galectin Therapeutics

-$0.27 (-6.84%) Today
-$0.14 (-3.80%) As of 9:48 AM UTC after-hours

Why Robinhood?

You can buy or sell GALT and other stocks, options, and ETFs commission-free!

About GALT

Galectin Therapeutics Inc. Common Stock, also called Galectin Therapeutics, is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer.

CEO
Joel Lewis
Employees
6
Headquarters
Norcross, Georgia
Founded
2000

GALT Key Statistics

Market Cap
201.28M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
4.13M
High Today
$4.16
Low Today
$3.54
Open Price
$4.16
Volume
1.00M
52 Week High
$5.70
52 Week Low
$1.82

GALT Earnings

-$0.17
-$0.11
-$0.06
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available May 17, Pre-Market

You May Also Like

TNA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure